In this news article, TBJ covers in depth the history and achievements of BioAgilytix’ CEO, Jim Datin. He has been at the helm of BioAgilytix since November 2013 and has…
In this news article, our CEO Jim Datin discusses with Triangle Business Journal about BioAgilytix’ performance and the challenges they have experienced in 2020.
HAMBURG, Germany — BioAgilytix is thrilled to announce the addition of a new diagnostics tool to their growing list of cutting-edge bioanalysis instruments. With the help of this innovative instrument,…
Bioanalytical life science company to invest $61.5 million RALEIGH: BioAgilytix Labs, LLC, a leading life science testing company, will create 878 jobs and invest $61.5 million in Durham, Governor Roy…
BioAgilytix has recently been awarded the 2020 Fast 50 Award by Triangle Business Journal as one of the fastest-growing private companies within our region.
September 22, 2020-Durham, NC-BioAgilytix Labs is pleased to announce the appointment of Kennon Broadhurst to its Commercial Leadership team as Vice President of Global Marketing. Kennon joins BioAgilytix after having…
PRNewswire covers the news of welcoming Kennon Broadhurst to the BioAgilytix team, bringing with him over 26 years of experience in sales, marketing and product commercialization experience.
BioAgilytix has received its Certificate of Accreditation for high complexity testing in the diagnostic immunology specialty from the Commission on Office Laboratory Accreditation (COLA) for its U.S. facility in Durham, North Carolina.
Dr. Fjording will be based at BioAgilytix’s European laboratory in Hamburg, Germany and will provide scientific and regulatory oversight to BioAgilytix’s team in the development and implementation of strategies for bioanalytical assay development and regulated assay validation.
The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.
Platforms
Services